CD38 and B-cell chronic lymphocytic leukemia: Musolino et al. found that patients with B-CLL have higher serum levels of carbonyl groups than controls, and also that these levels correlate positively with CD38 expression and negatively with ZAP70 expression (both markers of poor outcome), proposing them as a prognostic factor in B-CLL [36].